STASON

What this means for you

Registered since 26 Aug 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Aug 2018).

Record

Serial number

77203359

Registration number

3491255

Mark type

Stylized text

Filed

11 Jun 2007

Published for opposition

10 Jun 2008

Registered

26 Aug 2008

Next maintenance due

26 Aug 2018

Attorney of record

D. Whitlow Bivens

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ [ in ophthalmology ] and for gastroenterological disorders

Owner

• Stason Pharmaceuticals, Inc., Irvine, CA, US
• Stason Pharmaceuticals, Inc., Irvine, CA, US
• Stason Pharmaceuticals, Inc., Irvine, CA, US

Prosecution history

• 01 Sept 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 01 Sept 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 01 Sept 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 01 Sept 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 24 Aug 2018 — TEAS SECTION 8 & 9 RECEIVED
• 26 Aug 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 11 Mar 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 11 Mar 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 09 Mar 2015 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
• 15 Jan 2015 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
• 09 Jan 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 19 Dec 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 19 Dec 2014 — TEAS SECTION 8 & 15 RECEIVED
• 26 Aug 2008 — REGISTERED-PRINCIPAL REGISTER
• 10 Jun 2008 — PUBLISHED FOR OPPOSITION